HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dengwen Li Selected Research

Familial cylindromatosis

8/2010Tumour suppressor CYLD is a negative regulator of the mitotic kinase Aurora-B.
4/2008The tumor suppressor CYLD regulates microtubule dynamics and plays a role in cell migration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dengwen Li Research Topics

Disease

16Neoplasms (Cancer)
01/2021 - 03/2008
10Breast Neoplasms (Breast Cancer)
01/2020 - 05/2009
8Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 06/2010
5Neoplasm Metastasis (Metastasis)
01/2020 - 01/2014
4Carcinogenesis
01/2019 - 03/2008
4Inflammation (Inflammations)
01/2018 - 01/2014
2Neurodegenerative Diseases (Neurodegenerative Disease)
04/2021 - 04/2011
2Pathologic Processes
01/2021 - 02/2016
2Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2016 - 05/2008
2Parkinson Disease (Parkinson's Disease)
04/2011 - 05/2009
2Familial cylindromatosis
08/2010 - 04/2008
1Infections
01/2022
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Multiple Myeloma
01/2020
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2020
1Anemia
11/2019
1Lung Neoplasms (Lung Cancer)
11/2017
1Lymphatic Metastasis
02/2016
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2015
1Cough
01/2015
1Ciliopathies
11/2014
1Wounds and Injuries (Trauma)
04/2014
1Cardiovascular Diseases (Cardiovascular Disease)
04/2014
1Neuroblastoma
01/2014
1Parkinsonian Disorders (Parkinsonism)
04/2013
1Leukemia
01/2013
1Hypoxia (Hypoxemia)
06/2007

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
01/2019 - 04/2008
6Deubiquitinating EnzymesIBA
01/2021 - 05/2010
6Carrier Proteins (Binding Protein)IBA
01/2019 - 04/2008
5Histone Deacetylase 6IBA
01/2020 - 11/2013
5Messenger RNA (mRNA)IBA
11/2017 - 11/2013
5Pharmaceutical PreparationsIBA
06/2017 - 05/2009
5cytoplasmic linker protein 170 (restin)IBA
04/2014 - 03/2012
4Paclitaxel (Taxol)FDA LinkGeneric
06/2017 - 05/2009
3TubulinIBA
01/2022 - 01/2014
3Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2014
3Phosphotransferases (Kinase)IBA
11/2017 - 06/2007
3Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
04/2013 - 05/2009
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2020 - 01/2014
2MAP Kinase Kinase Kinase 5IBA
11/2017 - 11/2016
2Glycine (Aminoacetic Acid)FDA LinkGeneric
08/2010 - 04/2008
1Cytoskeletal ProteinsIBA
04/2021
1Indicators and Reagents (Reagents)IBA
01/2019
1MonosaccharidesIBA
01/2018
1Threonine (L-Threonine)FDA Link
11/2017
1Calcium-Binding ProteinsIBA
01/2017
1CytokinesIBA
01/2017
1Interleukin-17 (Interleukin 17)IBA
01/2017
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
03/2016
1Lysine (L-Lysine)FDA Link
03/2016
1UbiquitinIBA
03/2016
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
03/2016
1Centrosomal Associated ProteinsIBA
02/2016
1CarbohydratesIBA
02/2016
1AntigensIBA
02/2016
1pericentrinIBA
02/2016
1AgarIBA
02/2016
1KinesinsIBA
01/2016
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2015
1Noscapine (Narcotine)IBA
01/2015
1tubacinIBA
01/2014
1Rho Guanine Nucleotide Exchange FactorsIBA
01/2013
1Polo-Like Kinase 1IBA
10/2012
1GemcitabineFDA Link
10/2012
1Farnesyltranstransferase (Farnesyltransferase)IBA
05/2012
1Caspase 3 (Caspase-3)IBA
03/2012
1Proteasome Endopeptidase Complex (Proteasome)IBA
04/2011
1Adenosine Triphosphatases (ATPase)IBA
06/2010
1Dynactin ComplexIBA
05/2008
1Vinca AlkaloidsIBA
03/2008
1Aurora KinasesIBA
03/2008
1CREB-Binding ProteinIBA
06/2007
1Histone Deacetylases (Histone Deacetylase)IBA
06/2007
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
06/2007
1Hypoxia-Inducible Factor 1IBA
06/2007

Therapy/Procedure

6Therapeutics
01/2020 - 06/2010
4Drug Therapy (Chemotherapy)
11/2019 - 03/2008